Both in Pharmaceuticals
Biote vs SCYNEXIS
Over the past year BTMD returned −57.0% and SCYX returned −23.8%; their daily moves had a correlation of -0.06.
BTMD −57.0% SCYX −23.8%Growth of $1, one year, split-adjusted
| Metric | BTMD | SCYX |
|---|---|---|
| Price | $1.23 | $3.84 |
| Market cap | $35.3M | $38.2M |
| Today | +9.82% | −2.54% |
| 1 month | +7.9% | −20.7% |
| 6 months | −44.1% | −51.1% |
| Year to date | −52.7% | −24.1% |
| 1 year | −56.5% | −24.8% |
| Revenue growth (YoY) | −9.5% | −82.8% |
| Gross margin | 65.4% | 100.0% |
| Net margin | −14.8% | 3147.7% |
| P/E (TTM) | 6.0× | — |
| Price / sales | 0.2× | 2.0× |
| Net cash | -$110.3M | $54.1M |
| Dividend yield | — | — |
| Volatility (60d) | 69.6% | 63.6% |
| Short % of float | 5.4% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).